Clinical Trial Update: Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of Conbercept for macular edema secondary to retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Vein Occlusion

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: Chengdu Kanghong Biotech Co., Ltd. | Conditions: Retinal Vein Occlusion | Phase 2 | Status: UNKNOWN